2831-Vance, Gail

Gail H. Vance, MD

Sutphin Professor Emeritus of Cancer Genetics

Professor Emeritus of Medical & Molecular Genetics

Professor Emeritus of Pathology & Laboratory Medicine

Phone
(317) 274-5750
Address
IB 159
MMGE
IN
Indianapolis, IN
PubMed:

Bio

Dr. Vance received her M.D. in 1980 from Michigan State University, East Lansing, Michigan. She has been with the Indiana University Department of Medical and Molecular Genetics since September, 1989. From 1989 to 1992, she served as a Visiting Assistant Professor. In 1992, she was appointed assistant professor in the Department of Medical and Molecular Genetics and promoted to associate professor in 1998. Dr. Vance assumed the duties of assistant director of the Cytogenetic Laboratories in 1994 and director of the laboratories in 1998. Dr. Vance served as Interim Chairperson of the Department of Medical and Molecular Genetics from 1999-2002, and as co-interim chairperson from 2014-2015. 

Dr. Vance is certified in Pediatrics (American Board of Pediatrics), Clinical Pathology (American Board of Pathology), and in Clinical Genetics and Clinical Cytogenetics (American Board of Medical Genetics). She holds the rank of Professor in the Department of Medical & Molecular Genetics, and the Department of Pathology & Laboratory Medicine.

With Cindy Hunter, M.S., Dr. Vance directs the Indiana Familial Cancer Program, which provides genetic counseling, risk assessment and genetic testing to individuals with an elevated risk for developing cancer. Currently, the IFCC offers counseling for patients with high risk for breast and ovarian cancer, familial adenomatous polyposis, and hereditary non-polyposis colon cancer, Li Fraumeni syndrome and other familial cancer syndromes. She also directs the state's only Familial Pancreatic Cancer Registry, which collects information on patients with family histories of pancreatic cancer. Dr. Vance also serves as a clinical geneticist, seeing families in genetics clinics held in Indianapolis, Carmel, and Evansville.

Key Publications

Vance GH, Lotodo T, Kigen N, Stohler R, Choi H, Njuguna F, Moormann A, Kirwa E, Langat S, Loehrer P, Vik T. Improvement in diagnosis in children with Burkitt lymphoma in Kenya: Implementation of fluorescence in situ hybridization testing for MYC and the MYC/IGH translocation.  Ecancermedicalscience,2023; 17:1505. PMID 37113725.

Miller Q, Omer S, Al-Hader A, Vance GH, Zhang Chen. Malignant gastrointestinal neuroectodermal tumor arising in the extrahepatic bile ducts: A case report of a rare neoplasm in an unusual anatomic location. BMJ Case Rep. 2022; 15(7): e250094 PMID 35858740.

Vance GH and Khan WA. Utility of fluorescence in situ hybridization in clinical and research applications. Clinics in Laboratory Medicine. Tsongalis GJ ed. December 2022, PMID 36368783

Scouten RW, Wesson M, Wetherill L, Vance GH, Delk PR.  Genetic counseling program remediation practices for students underperforming in clinical skills: An exploratory study. Journal of Genetic Counseling 2023; PMID 37051800

McFadden JD, Hardesty JK, Schroeder C, Vance GH, Boris R. Referral patterns and genetic testing outcomes in a contemporary hereditary renal cancer clinic. Urologic Oncology 2024; 42(3) 72. PMID 38267302

Kevin TA. Booth, Rachael R. Schulte, Laurin Smith, Hongyu Gao, Ryan A. Stohler, Yunlong Liu, Shalini C. Reshmi, Gail H Vance. ZMIZ1::ABL1 Fusion: An Uncommon Molecular Event with Clinical Implications in Pediatric Cancer. Archives of Pathology and Laboratory Medicine 2024; May epub ahead of print. PMID 38749501

 

Looking for patient care?

To schedule an appointment with a faculty member physician of IU School of Medicine, contact Indiana University Health at 888-484-3258 or use the physician finder by clicking the button below.